Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

50.44
-1.9100-3.65%
Post-market: 50.600.1600+0.32%19:58 EDT
Volume:2.87M
Turnover:146.21M
Market Cap:4.88B
PE:-10.60
High:53.54
Open:51.51
Low:50.02
Close:52.35
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:1.75
T/O Rate:3.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:2.79
PE(LYR):-7.80

Loading ...

May 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 11, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 03, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Major Issues Report

8-K - Current report
Mar 14, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 01, 2022

Major Issues Report

8-K - Current report
Nov 01, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 27, 2022

Major Issues Report

8-K - Current report